Amplify Weight Loss Drug & Treatment ETF (THNR) Holdings $22.20 +0.67 (+3.11%) As of 05/2/2025 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Top 28 THNR HoldingsRankCompanyCurrent PriceWeightShares Held1LLYEli Lilly and Company$825.10+3.9%15.38%6182NVONovo Nordisk A/S$69.27+5.6%13.89%6,5263Chugai Pharmaceutical Co., Ltd.N/A5.94%3,7004Innovent Biologics, Inc.N/A5.43%27,0005WSTWest Pharmaceutical Services$211.27+0.5%5.23%7386Roche Holding AGN/A5.09%4827AMGNAmgen$281.22-0.9%5.05%5288AZNAstraZeneca$72.44+2.7%4.90%2,1609TMOThermo Fisher Scientific$423.69+0.9%4.84%32710PFEPfizer$24.19+1.1%4.81%6,450 Get the Latest News and Ratings for THNR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amplify Weight Loss Drug & Treatment ETF and its competitors with MarketBeat's FREE daily newsletter. 11TEVATeva Pharmaceutical Industries$16.22+3.8%4.56%10,03012MRKMerck & Co., Inc.$83.14-0.1%4.51%1,74413HIMSHims & Hers Health$40.98+13.3%3.70%4,05914Mitsubishi Chemical Group CorporationN/A3.52%22,50015Zealand Pharma A/SN/A2.42%1,10616GPCRStructure Therapeutics$27.09-0.9%1.78%2,84417VKTXViking Therapeutics$29.36+2.6%1.51%1,89418Gerresheimer AGN/A1.50%76619The United Laboratories International Holdings LimitedN/A1.45%26,00020Bachem Holding AGN/A1.40%70521Ypsomed Holding AGN/A1.11%8222Gubra A/SN/A0.67%36723Hanmi Pharm. Co., Ltd.N/A0.60%10824OPKOPKO Health$1.39+2.6%0.26%5,36325DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A0.24%66,661,55026ALTAltimmune$5.77+11.6%0.20%1,32327Short-Term Investment Trust - Invesco Government & Agency PortfolioN/A0.11%3,21628US DOLLARSN/A-0.12%3,547 Geographic ExposureUnited States70.2%Japan10.0%Cayman Islands7.2%Switzerland5.9%Denmark2.4%Germany1.6%Korea, Republic of0.6%Currency ExposureUSD70.2%JPY10.0%HKD7.2%CHF7.2%DKK3.1%EUR1.6%KRW0.6%Sector ExposureHealth Care94.9%Materials4.7%Consumer Discretionary0.2%Industry ExposureBiotechnology76.3%Health Care Equipment & Supplies10.1%Chemicals4.7%Health Care Providers & Services4.5%Pharmaceuticals2.4%Life Sciences Tools & Services1.6%Diversified Consumer Services0.2%SubIndustry ExposureBiotechnology76.3%Health Care Supplies5.9%Life Sciences Tools & Services5.8%Health Care Services4.5%Diversified Chemicals3.3%Pharmaceuticals2.6%Commodity Chemicals1.3%Coupon Exposure4-60.1%Maturity Exposure5-100.1% Related Companies and Tools Related Companies KraneShares MSCI One Belt One Road ETF Holdings Direxion Daily Crypto Industry Bear 1X Shares Holdings Harbor Corporate Culture Leaders ETF Holdings Westwood LBRTY Global Equity ETF Holdings iShares Neuroscience and Healthcare ETF Holdings Direxion Daily Crypto Industry Bull 2X Shares Holdings Xtrackers US Green Infrastructure Select Equity ETF Holdings StockSnips AI Powered Sentiment US All Cap ETF Holdings iShares Breakthrough Environmental Solutions ETF Holdings iShares Virtual Work and Life Multisector ETF Holdings This page (NYSEARCA:THNR) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy THNR Stock Free THNR Stock Alerts